Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BELOXAN: Docetaxel and Oxaliplatin in NSCLC
NCT01243775Phase 2Completed
- Sponsor
- Chonnam National University Hospital
- Start
- Nov 2010
- Primary completion
- Jan 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin in non-small cell lung cancer (NSCLC), sponsored by Chonnam National University Hospital. Started Nov 2010; status: completed.
02
Drugs
docetaxeloxaliplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01243775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243775.